Recombinant Human AMOTL2 Protein，His & GST

AMOTL2 (Angiomotin Like 2) is a member of the angiomotin family of proteins, which are primarily involved in various cellular processes such as cell migration, proliferation, and the regulation of tight junctions. Research into AMOTL2 has gained momentum due to its significant roles in physiological and pathological contexts, particularly in tumorigenesis and cancer metastasis. This protein is known to interact with several regulatory pathways, including those associated with Hippo signaling, which is crucial for controlling cell growth and maintaining tissue homeostasis. Dysregulation of AMOTL2 has been implicated in various cancer types, where it may influence tumor progression by modulating cellular behaviors and the tumor microenvironment. Moreover, studies have shown that AMOTL2 can affect angiogenesis and vascular permeability, further elevating its interest in the context of cancer research. Additionally, its potential as a therapeutic target has prompted efforts to investigate AMOTL2 as a biomarker for cancer diagnosis and prognosis. Understanding the full scope of AMOTL2's functions and mechanisms through recombinant protein studies could yield valuable insights into its contributions to cellular dynamics and reveal novel approaches for cancer treatment. Thus, the research surrounding AMOTL2 is critical for elucidating the intricate networks that govern cellular behavior and disease progression, representing a promising avenue for therapeutic intervention in oncology.